These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
595 related articles for article (PubMed ID: 16923954)
21. Neuropathologic characteristics of spinal cord lesions in sporadic Creutzfeldt-Jakob disease. Iwasaki Y; Yoshida M; Hashizume Y; Kitamoto T; Sobue G Acta Neuropathol; 2005 Nov; 110(5):490-500. PubMed ID: 16175355 [TBL] [Abstract][Full Text] [Related]
22. Analysis of prion strains by PrPSc profiling in sporadic Creutzfeldt-Jakob disease. Schoch G; Seeger H; Bogousslavsky J; Tolnay M; Janzer RC; Aguzzi A; Glatzel M PLoS Med; 2006 Feb; 3(2):e14. PubMed ID: 16354106 [TBL] [Abstract][Full Text] [Related]
23. Creutzfeldt-Jakob disease (CJD) with a mutation at codon 148 of prion protein gene: relationship with sporadic CJD. Pastore M; Chin SS; Bell KL; Dong Z; Yang Q; Yang L; Yuan J; Chen SG; Gambetti P; Zou WQ Am J Pathol; 2005 Dec; 167(6):1729-38. PubMed ID: 16314483 [TBL] [Abstract][Full Text] [Related]
24. Polymorphism at codon 129 of the prion protein gene determines cerebellar pathology in Creutzfeldt-Jakob disease. Schulz-Schaeffer WJ; Giese A; Windl O; Kretzschmar HA Clin Neuropathol; 1996; 15(6):353-7. PubMed ID: 8937783 [TBL] [Abstract][Full Text] [Related]
26. Dura mater graft-associated Creutzfeldt-Jakob disease in Japan: clinicopathological and molecular characterization of the two distinct subtypes. Yamada M; Noguchi-Shinohara M; Hamaguchi T; Nozaki I; Kitamoto T; Sato T; Nakamura Y; Mizusawa H Neuropathology; 2009 Oct; 29(5):609-18. PubMed ID: 19659940 [TBL] [Abstract][Full Text] [Related]
27. Clusterin solubility and aggregation in Creutzfeldt-Jakob disease. Freixes M; Puig B; Rodríguez A; Torrejón-Escribano B; Blanco R; Ferrer I Acta Neuropathol; 2004 Oct; 108(4):295-301. PubMed ID: 15235804 [TBL] [Abstract][Full Text] [Related]
28. Molecular typing of PrPres in human sporadic CJD brain tissue. Lewis V; Klug GM; Hill AF; Collins SJ Methods Mol Biol; 2008; 459():241-7. PubMed ID: 18576159 [TBL] [Abstract][Full Text] [Related]
29. Identification of distinct N-terminal truncated forms of prion protein in different Creutzfeldt-Jakob disease subtypes. Zanusso G; Farinazzo A; Prelli F; Fiorini M; Gelati M; Ferrari S; Righetti PG; Rizzuto N; Frangione B; Monaco S J Biol Chem; 2004 Sep; 279(37):38936-42. PubMed ID: 15247220 [TBL] [Abstract][Full Text] [Related]
30. Protease-sensitive conformers in broad spectrum of distinct PrPSc structures in sporadic Creutzfeldt-Jakob disease are indicator of progression rate. Kim C; Haldiman T; Cohen Y; Chen W; Blevins J; Sy MS; Cohen M; Safar JG PLoS Pathog; 2011 Sep; 7(9):e1002242. PubMed ID: 21931554 [TBL] [Abstract][Full Text] [Related]
31. A novel subtype of sporadic Creutzfeldt-Jakob disease with PRNP codon 129MM genotype and PrP plaques. Bayazid R; Orru' C; Aslam R; Cohen Y; Silva-Rohwer A; Lee SK; Occhipinti R; Kong Q; Shetty S; Cohen ML; Caughey B; Schonberger LB; Appleby BS; Cali I Acta Neuropathol; 2023 Jul; 146(1):121-143. PubMed ID: 37156880 [TBL] [Abstract][Full Text] [Related]
32. Association of prion protein genotype and scrapie prion protein type with cellular prion protein charge isoform profiles in cerebrospinal fluid of humans with sporadic or familial prion diseases. Schmitz M; Lüllmann K; Zafar S; Ebert E; Wohlhage M; Oikonomou P; Schlomm M; Mitrova E; Beekes M; Zerr I Neurobiol Aging; 2014 May; 35(5):1177-88. PubMed ID: 24360565 [TBL] [Abstract][Full Text] [Related]
33. Peripheral tissue involvement in sporadic, iatrogenic, and variant Creutzfeldt-Jakob disease: an immunohistochemical, quantitative, and biochemical study. Head MW; Ritchie D; Smith N; McLoughlin V; Nailon W; Samad S; Masson S; Bishop M; McCardle L; Ironside JW Am J Pathol; 2004 Jan; 164(1):143-53. PubMed ID: 14695328 [TBL] [Abstract][Full Text] [Related]
34. Prion Strain Characterization of a Novel Subtype of Creutzfeldt-Jakob Disease. Galeno R; Di Bari MA; Nonno R; Cardone F; Sbriccoli M; Graziano S; Ingrosso L; Fiorini M; Valanzano A; Pasini G; Poleggi A; Vinci R; Ladogana A; Puopolo M; Monaco S; Agrimi U; Zanusso G; Pocchiari M J Virol; 2017 Jun; 91(11):. PubMed ID: 28298604 [TBL] [Abstract][Full Text] [Related]
36. Preventing misfolding of the prion protein by trimethylamine N-oxide. Bennion BJ; DeMarco ML; Daggett V Biochemistry; 2004 Oct; 43(41):12955-63. PubMed ID: 15476389 [TBL] [Abstract][Full Text] [Related]
37. Creutzfeldt-Jakob disease and inclusion body myositis: abundant disease-associated prion protein in muscle. Kovacs GG; Lindeck-Pozza E; Chimelli L; Araújo AQ; Gabbai AA; Ströbel T; Glatzel M; Aguzzi A; Budka H Ann Neurol; 2004 Jan; 55(1):121-5. PubMed ID: 14705121 [TBL] [Abstract][Full Text] [Related]
38. Incidence and spectrum of sporadic Creutzfeldt-Jakob disease variants with mixed phenotype and co-occurrence of PrPSc types: an updated classification. Parchi P; Strammiello R; Notari S; Giese A; Langeveld JP; Ladogana A; Zerr I; Roncaroli F; Cras P; Ghetti B; Pocchiari M; Kretzschmar H; Capellari S Acta Neuropathol; 2009 Nov; 118(5):659-71. PubMed ID: 19718500 [TBL] [Abstract][Full Text] [Related]
39. Atypical Creutzfeldt-Jakob disease with PrP-amyloid plaques in white matter: molecular characterization and transmission to bank voles show the M1 strain signature. Rossi M; Saverioni D; Di Bari M; Baiardi S; Lemstra AW; Pirisinu L; Capellari S; Rozemuller A; Nonno R; Parchi P Acta Neuropathol Commun; 2017 Nov; 5(1):87. PubMed ID: 29169405 [TBL] [Abstract][Full Text] [Related]
40. Immunoreactivity enhancement with chelators for increasing the detection sensitivity of human PrPSc by Western blotting. Kuczius T; Brinkmann B; Grassi J Neurochem Int; 2007 Jan; 50(1):102-8. PubMed ID: 16962685 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]